Current and Emerging Microbiome-Targeted Therapies to Prevent Recurrent CDI: A Stakeholder Interchange Report
Advertisement
Advertisement
Trending on AJMC
1
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
2
TrumpRx Launch Brings Savings—and Uncertainty
3
Exploring Identity, Appearance Experiences Among Patients With Alopecia
4
5 Things to Know About the Oral GLP-1 Era
5
